Michel Jadoul
About
In The Last Decade
Michel Jadoul
252 papers receiving 11.1k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Nephrology 4.5k
- Epidemiology 2.0k
- Pulmonary and Respiratory Medicine 1.8k
- Hepatology 1.8k
- Surgery 1.4k
Countries citing papers authored by Michel Jadoul
This map shows the geographic impact of Michel Jadoul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Jadoul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Jadoul more than expected).
Fields of papers citing papers by Michel Jadoul
This network shows the impact of papers produced by Michel Jadoul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Jadoul. The network helps show where Michel Jadoul may publish in the future.
Co-authorship network of co-authors of Michel Jadoul
This figure shows the co-authorship network connecting the top 25 collaborators of Michel Jadoul. A scholar is included among the top collaborators of Michel Jadoul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Jadoul. Michel Jadoul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 5 | |
| 6 | 12 | |
| 7 | 2 | |
| 8 | 98 | |
| 9 | 1 | |
| 10 | 3 | |
| 11 | 0 | |
| 12 | 25 | |
| 13 | 61 | |
| 14 | 32 | |
| 15 | 22 | |
| 16 | Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis breakdown → | 420 |
| 17 | 3 | |
| 18 | 217 | |
| 19 | Cinacalcet HCl controls secondary hyperparathyroidism (HPT) regardless of gender, race, age, and geography in patients with chronic kidney disease (CKD) receiving dialysis. | 2 |
| 20 | Postmortem Joint Beta-2m Amyloidosis As a Function of Hemodialysis Duration and Patients Age | 10 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.